FDA — authorised 2 August 1982
- Marketing authorisation holder: TARO PHARMS NORTH
- Status: approved
🇺🇸 Ovide in United States
FDA authorised Ovide on 2 August 1982
Marketing authorisations
FDA — authorised 2 August 1982
- Application: NDA018613
- Marketing authorisation holder: TARO
- Local brand name: OVIDE
- Indication: LOTION — TOPICAL
- Status: approved
FDA — authorised 6 March 2009
- Application: ANDA078743
- Marketing authorisation holder: PHARMOBEDIENT
- Local brand name: MALATHION
- Indication: LOTION — TOPICAL
- Status: approved
FDA — authorised 23 May 2012
- Application: ANDA091559
- Marketing authorisation holder: SUVEN PHARMS
- Local brand name: MALATHION
- Indication: LOTION — TOPICAL
- Status: approved
Ovide in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in United States
Frequently asked questions
Is Ovide approved in United States?
Yes. FDA authorised it on 2 August 1982; FDA authorised it on 2 August 1982; FDA authorised it on 6 March 2009.
Who is the marketing authorisation holder for Ovide in United States?
TARO PHARMS NORTH holds the US marketing authorisation.